Related Experiment Video

Updated: Jul 12, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Pseudomembranous Colitis Caused by C. difficile

Surawicz1, McFarland

  • 1Division of Gastroenterology, Box 359773, Harborview Medical Center, 325 9th Avenue, Seattle, WA 98104, USA.

Current Treatment Options in Gastroenterology
|November 30, 2000
PubMed

Insights

Pseudomembranous colitis (PMC), a severe C. difficile infection, is treated with metronidazole or vancomycin. Recurrent cases benefit from antibiotics plus biotherapeutics, while prevention requires hygiene and antibiotic stewardship.

Area of Science:

  • Infectious Diseases
  • Gastroenterology
  • Microbiology

Background:

  • Pseudomembranous colitis (PMC) presents significant clinical challenges due to its severity, rising incidence, potential complications, and association with antibiotic-resistant bacteria.
  • Clostridioides difficile (C. difficile) infection is a primary cause of PMC, particularly in patients experiencing diarrhea during or after antibiotic treatment.

Purpose of the Study:

  • To outline the current understanding and management strategies for pseudomembranous colitis.
  • To provide guidance on the appropriate use of antibiotics and biotherapeutics for C. difficile infections and recurrent disease.

Main Methods:

  • Review of existing literature on C. difficile infection and PMC.
  • Analysis of treatment guidelines for metronidazole and vancomycin efficacy.
  • Discussion of strategies for managing recurrent C. difficile disease and preventing hospital-acquired infections.

Main Results:

  • Metronidazole is recommended as the first-line treatment for PMC, with vancomycin reserved for severe cases or treatment failures.
  • Recurrent C. difficile infections are effectively managed with a combination of antibiotics and biotherapeutic agents.
  • Effective prevention strategies include rigorous hand hygiene, environmental disinfection, and judicious antibiotic use.

Conclusions:

  • Optimal management of PMC involves appropriate antibiotic selection and consideration of biotherapeutics for recurrent disease.
  • Preventing the spread of C. difficile requires a multi-faceted approach including infection control measures and antibiotic stewardship.

More Related Videos

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R2029106:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

Related Concept Videos

Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Diverticular Disease of the Colon01:27

Diverticular Disease of the Colon

Diverticular disease involves the formation of diverticula—small sac-like outpouchings of the colonic wall—and their complications. It most commonly affects the sigmoid colon due to higher intraluminal pressure and structural vulnerability. It results from structural weakness and increased pressure in the colon, producing pseudodiverticula that may remain silent or progress to inflammation and serious complications.Structure of DiverticulaIn diverticulosis, these outpouchings are...